Siest G.
66
Coauthors
6
Documentos
Volumen de publicaciones por año
Cargando gráfico
| Año de publicación | Num. Publicaciones |
|---|---|
| 2005 | 1 |
| 2007 | 1 |
| 2011 | 1 |
| 2013 | 1 |
| 2016 | 1 |
| 2017 | 1 |
Publicaciones por áreas de conocimiento
Cargando gráfico
| Área de conocimiento | Num. Publicaciones |
|---|---|
| Farmacología | 9 |
| Genética | 2 |
| Psicopatología | 1 |
Publicaciones por áreas temáticas
Cargando gráfico
| Área temática | Num. Publicaciones |
|---|---|
| Farmacología y terapéutica | 4 |
| Medicina y salud | 4 |
| Enfermedades | 3 |
| Dirección general | 2 |
| Ética del trabajo | 1 |
Principales fuentes de datos
| Origen | Num. Publicaciones |
|---|---|
| Scopus | 6 |
| Google Scholar | 0 |
| RRAAE | 0 |
Cargando gráfico
Coautores destacados por número de publicaciones
| Coautor | Num. Publicaciones |
|---|---|
| Adrián LLerena | 6 |
| Manolopoulos V.G. | 3 |
| Stathopoulou M.G. | 2 |
| Penãs-Lledó E.M. | 2 |
| Visvikis-Siest S. | 2 |
| Wong S. | 2 |
| Shahabi P. | 1 |
| Silva Santos L. | 1 |
| El Shamieh S. | 1 |
| Monteiro P. | 1 |
Cargando gráfico
Top Keywords
Cargando gráfico
Publicaciones del autor
Progress in pharmacogenetics: Consortiums and new strategies
ReviewAbstract: Pharmacogenetics (PGx), as a field dedicated to achieving the goal of personalized medicine (PM), isPalabras claves:next-generation sequencing (NGS) technologies, personalized medicine, pharmacogenetics, standardization; translationAutores:Adrián LLerena, Carracedo Á., Dopazo J., Latorre A., Maroñas O., Pirmohamed M., Rodríguez-Antona C., Siest G.Fuentes:scopusPharmacogenomics and personalized medicine in clinical practice
Conference ObjectAbstract: The Santorini Conference on prospective biology, genomics and pharmacogenomics occurs every 2 years.Palabras claves:Biomarkers, cytochromes, personalized medicine, pharmacogenetics, Pharmacogenomics, theranosticsAutores:Adrián LLerena, Dechairo B., Huriez A., J Yeo K., KüÃhn A., Manolopoulos V.G., Ragia G., Siest G., Van Schaik R.H.N.Fuentes:scopusNewly identified synergy between clopidogrel and calcium-channel blockers for blood pressure regulation possibly involves CYP2C19 rs4244285
ArticleAbstract:Palabras claves:Blood pressure, Calcium-channel blockers, clopidogrel, CYP2C19 polymorphism, synergyAutores:Adrián LLerena, El Shamieh S., Monteiro P., Penãs-Lledó E.M., Shahabi P., Siest G., Silva Santos L., Stathopoulou M.G., Thilly N., Visvikis-Siest S.Fuentes:scopusVEGF-related polymorphisms identified by GWAS and risk for major depression
ArticleAbstract: Depression is a common, severe, disabling mental disease that affects millions of people of all agesPalabras claves:Autores:Adrián LLerena, Cobaleda J., de Andrés F., Delgado A., Lamont J., Martin M., Murray H., Penãs-Lledó E.M., Siest G., Stathopoulou M.G., Visvikis-Siest S., Xie T.Fuentes:scopusPharmacogenomics education: International Society of Pharmacogenomics recommendations for medical, pharmaceutical, and health schools Deans of Education
ArticleAbstract: Pharmacogenomics would be instrumental for the realization of personalized medicine in coming decadePalabras claves:Adverse drug reactions (ADRs), Continuing medical education, Cytochrome P450 enzymes, Education, International Society of Pharmacogenetics (ISP), personalized medicine, pharmacogenetics, Thiopurine methyltransferase (TPMT)Autores:Adrián LLerena, Dedoussis G., Flordellis C.S., Fuhr U., Gurwitz D., Kirchheiner J., Licinio J., Lunshof J.E., Manolopoulos V.G., Sheffield L.J., Siest G., Torricelli F., Vasiliou V., Wong S.Fuentes:scopus